Cart is empty One in 10 medical products circulating in low—and middle-income countries (LMICs) is substandard or fake, with the majority in Sub-Saharan Africa being antibacterial and antimalarial drugs. The unchecked spread of these products threatens lives and undermines health care systems already struggling with access and quality.
Leave A Comment